Algae Health Sciences (AlgaeHealth), a subsidiary of BGG, has attained Non-GMO Project Verified status for its flagship AstaZine natural astaxanthin supercritical CO2 oleoresin extracts produced in Germany and whole-food based astaxanthin-rich algae powder.
In conjunction with becoming the world’s first organically certified Haematococcus pluvialis microalgae product in March 2016 and bearing the NAXA Verified Seal, AstaZine has now become the clear choice for brands concerned with having the highest-quality third-party audited astaxanthin raw materials in their finished products, the company said. “The Non-GMO Project Verification seal is known and trusted in the U.S. market and around the world,” said Joe Huff, CEO of AlgaeHealth’s North American operations. “We’re happy to now offer this additional third-party certification to brands incorporating our AstaZine.”
AlgaeHealth’s AstaZine continues an industry-leading trajectory of regulatory and quality achievements over the last two years, including:
- The first astaxanthin NDI notification with the U.S. FDA over 12 mg per day (at 24 mg per day).
- The first company to gain two Novel Food Approvals in the EU for different astaxanthin extraction methods.
- Submission of 239 Structure/Function claims for astaxanthin to FDA without objection.
- And the first organically certified Haematococcus pluvialis product.